EMRYLDA Trademark

Trademark Overview

On Thursday, November 19, 2015, a trademark application was filed for EMRYLDA with the United States Patent and Trademark Office. The USPTO has given the EMRYLDA trademark a serial number of 86825759. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2019. This trademark is owned by Glaxo Group Limited. The EMRYLDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
emrylda

General Information

Serial Number86825759
Word MarkEMRYLDA
Filing DateThursday, November 19, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 24, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 22, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 18, 2018EXTENSION 5 GRANTED
Monday, December 10, 2018EXTENSION 5 FILED
Tuesday, December 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018EXTENSION 4 GRANTED
Wednesday, June 13, 2018EXTENSION 4 FILED
Wednesday, June 13, 2018TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 4, 2017EXTENSION 3 GRANTED
Saturday, November 4, 2017EXTENSION 3 FILED
Saturday, November 4, 2017TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 2 GRANTED
Tuesday, June 13, 2017EXTENSION 2 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2016EXTENSION 1 GRANTED
Thursday, December 1, 2016EXTENSION 1 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, June 21, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2016ASSIGNED TO EXAMINER
Tuesday, November 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 23, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

emrylda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological